PT-141 is a cutting-edge cyclic melanocortin agonist that demonstrates potential in the treatment of sexual dysfunction. This novel compound acts by enhancing specific receptors throughout the body, causing to enhanced sexual response. Research studies have revealed that PT-141 could remarkably treat a range of sexual dysfunctions in both men and